Quest Partners LLC Arcturus Therapeutics Holdings Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Quest Partners LLC holds 35,282 shares of ARCT stock, worth $460,782. This represents 0.04% of its overall portfolio holdings.
Number of Shares
35,282
Previous 7,142
394.01%
Holding current value
$460,782
Previous $121 Million
208.28%
% of portfolio
0.04%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ARCT
# of Institutions
161Shares Held
26.4MCall Options Held
312KPut Options Held
96.5K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$61.3 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$34.6 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.93MShares$25.2 Million0.27% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.93MShares$25.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$22.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $347M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...